Skip to main content

Advertisement

SpringerLink
Log in

Dynamic testing in Cushing’s syndrome

  • Published:
Pituitary Aims and scope Submit manuscript

Abstract

Endogenous Cushing’s syndrome (CS) results from chronic exposure to excess glucocorticoids. CS can be ACTH-dependent, caused by ACTH-secreting pituitary or ectopic tumours, or ACTH-independent, caused by cortisol-secreting adrenal tumours. CS can be an extremely difficult diagnosis to make, and assessment will include clinical, biochemical and radiological evaluation. Several screening tests are used for the confirmation of hypercortisolaemia and its differentiation from other, more frequent, clinical abnormalities, such as simple obesity, hypertension, depression etc. Other dynamic tests are useful for establishing the aetiology. We have reviewed the current literature on the diagnosis of CS, and based on these data and our own experience, suggest the most useful tests and diagnostic criteria to be used. We conclude that even though laboratory testing is a fundamental part of the investigation of patients with CS, the interpretation of the tests should always be performed with extreme care, as none of the tests has proven fully capable of distinguishing all cases of CS. The biochemical results should be interpreted jointly with the clinical aspects and the radiology findings in a probabilistic matrix, and not as part of a uniform algorithm.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Ross NS (1994) Epidemiology of Cushing’s syndrome and subclinical disease. Endocrinol Metab Clin North Am 23:539–546

    PubMed  CAS  Google Scholar 

  2. Plotz CM, Knowlton AI, Ragan C (1952) The natural history of Cushing’s syndrome. Am J Med 13:597–614

    Article  PubMed  CAS  Google Scholar 

  3. Lacroix A, Bourdeau I (2005) Bilateral adrenal Cushing’s syndrome: macronodular adrenal hyperplasia and primary pigmented nodular adrenocortical disease. Endocrinol Metab Clin North Am 34:441–458

    Article  PubMed  CAS  Google Scholar 

  4. Lacroix A, Baldacchino V, Bourdeau I, Hamet P, Tremblay J (2004) Cushing’s syndrome variants secondary to aberrant hormone receptors. Trends Endocrinol Metab 15:375–382

    PubMed  CAS  Google Scholar 

  5. Young WF Jr., Carney JA, Musa BU, Wulffraat NM, Lens JW, Drexhage HA (1989) Familial Cushing’s syndrome due to primary pigmented nodular adrenocortical disease. Reinvestigation 50 years later. N Engl J Med 321:1659–1664

    Article  PubMed  Google Scholar 

  6. Newell-Price J, Bertagna X, Grossman AB, Nieman LK (2006) Cushing’s syndrome. Lancet 367:1605–1617

    Article  PubMed  CAS  Google Scholar 

  7. Arnaldi G, Angeli A, Atkinson AB et al (2003) Diagnosis and complications of Cushing’s syndrome: a consensus statement. J Clin Endocrinol Metab 88:5593–5602

    Article  PubMed  CAS  Google Scholar 

  8. Newell-Price J, Grossman A (1999) Diagnosis and management of Cushing’s syndrome. Lancet 353:2087–2088

    Article  PubMed  CAS  Google Scholar 

  9. Nieman LK, Ilias I (2005) Evaluation and treatment of Cushing’s syndrome. Am J Med 118:1340–1346

    Article  PubMed  Google Scholar 

  10. Newell-Price J, Trainer P, Besser M, Grossman A (1998) The diagnosis and differential diagnosis of Cushing’s syndrome and pseudo-Cushing’s states. Endocrine Rev 19:647–672

    Article  CAS  Google Scholar 

  11. Cizza G, Nieman LK, Doppman JL et al (1996) Factitious Cushing syndrome. J Clin Endocrinol Metab 81:3573–3577

    Article  PubMed  CAS  Google Scholar 

  12. Yanovski JA, Cutler GB Jr., Chrousos GP, Nieman LK (1993) Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing’s syndrome from pseudo-Cushing’s states. JAMA 269:2232–2238

    Article  PubMed  CAS  Google Scholar 

  13. Makras P, Toloumis G, Papadogias D, Kaltsas GA, Besser M (2006) The diagnosis and differential diagnosis of endogenous Cushing’s syndrome. Hormones (Athens) 5:231–250

    Google Scholar 

  14. Wood PJ, Barth JH, Freedman DB, Perry L, Sheridan B (1997) Evidence for the low dose dexamethasone suppression test to screen for Cushing’s syndrome–recommendations for a protocol for biochemistry laboratories. Ann Clin Biochem 34(Pt 3):222–229

    PubMed  CAS  Google Scholar 

  15. Kennedy L, Atkinson AB, Johnston H, Sheridan B, Hadden DR (1984) Serum cortisol concentrations during low dose dexamethasone suppression test to screen for Cushing’s syndrome. Br Med J (Clin Res Ed) 289:1188–1191

    Article  CAS  Google Scholar 

  16. Newell-Price J, Trainer P, Perry L, Wass J, Grossman A, Besser M (1995) A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing’s syndrome. Clin Endocrinol (Oxf) 43:545–550

    Article  CAS  Google Scholar 

  17. Putignano P, Kaltsas GA, Satta MA, Grossman AB (1998) The effects of anti-convulsant drugs on adrenal function. Horm Metab Res 30:389–397

    PubMed  CAS  Google Scholar 

  18. Papanicolaou DA, Mullen N, Kyrou I, Nieman LK (2002) Nighttime salivary cortisol: a useful test for the diagnosis of Cushing’s syndrome. J Clin Endocrinol Metab 87:4515–4521

    Article  PubMed  CAS  Google Scholar 

  19. Raff H, Raff JL, Findling JW (1998) Late-night salivary cortisol as a screening test for Cushing’s syndrome. J Clin Endocrinol Metab 83:2681–2686

    Article  PubMed  CAS  Google Scholar 

  20. Findling JW, Raff H (2006) Cushing’s Syndrome: important issues in diagnosis and management. J Clin Endocrinol Metab 91:3746–3753

    Article  PubMed  CAS  Google Scholar 

  21. Papanicolaou DA, Yanovski JA, Cutler GB Jr., Chrousos GP, Nieman LK (1998) A single midnight serum cortisol measurement distinguishes Cushing’s syndrome from pseudo-Cushing states. J Clin Endocrinol Metab 83:1163–1167

    Article  PubMed  CAS  Google Scholar 

  22. Putignano P, Toja P, Dubini A, Pecori GF, Corsello SM, Cavagnini F (2003) Midnight salivary cortisol versus urinary free and midnight serum cortisol as screening tests for Cushing’s syndrome. J Clin Endocrinol Metab 88:4153–4157

    Article  PubMed  CAS  Google Scholar 

  23. Baid SK, Sinaii N, Wade M, Rubino D, Nieman LK (2007) Radioimmunoassay and tandem mass spectrometry measurement of bedtime salivary cortisol levels: a comparison of assays to establish hypercortisolism. J Clin Endocrinol Metab 92:3102–3107

    Article  PubMed  CAS  Google Scholar 

  24. Castro M, Elias PC, Quidute AR, Halah FP, Moreira AC (1999) Out-patient screening for Cushing’s syndrome: the sensitivity of the combination of circadian rhythm and overnight dexamethasone suppression salivary cortisol tests. J Clin Endocrinol Metab 84:878–882

    Article  PubMed  CAS  Google Scholar 

  25. Hellman L, Weitzman ED, Roffwarg H, Fukushima DK, Yoshida K (1970) Cortisol is secreted episodically in Cushing’s syndrome. J Clin Endocrinol Metab 30:686–689

    Article  PubMed  CAS  Google Scholar 

  26. Krieger DT, Allen W, Rizzo F, Krieger HP (1971) Characterization of the normal temporal pattern of plasma corticosteroid levels. J Clin Endocrinol Metab 32:266–284

    PubMed  CAS  Google Scholar 

  27. Crapo L (1979) Cushing’s syndrome: a review of diagnostic tests. Metabolism 28:955–977

    Article  PubMed  CAS  Google Scholar 

  28. Butler PW, Besser GM (1968) Pituitary-adrenal function in severe depressive illness. Lancet 1:1234–1236

    Article  PubMed  CAS  Google Scholar 

  29. Ross RJ, Miell JP, Holly JM et al (1991) Levels of GH binding activity, IGFBP-1, insulin, blood glucose and cortisol in intensive care patients. Clin Endocrinol (Oxf) 35:361–367

    Article  CAS  Google Scholar 

  30. Reimondo G, Allasino B, Bovio S, Paccotti P, Angeli A, Terzolo M (2005) Evaluation of the effectiveness of midnight serum cortisol in the diagnostic procedures for Cushing’s syndrome. Eur J Endocrinol 153:803–809

    Article  PubMed  CAS  Google Scholar 

  31. Martin NM, Dhillo WS, Banerjee A et al (2006) Comparison of the dexamethasone-suppressed corticotropin-releasing hormone test and low-dose dexamethasone suppression test in the diagnosis of Cushing’s syndrome. J Clin Endocrinol Metab 91:2582–2586

    Article  PubMed  CAS  Google Scholar 

  32. Gatta B, Chabre O, Cortet C et al (2007) Reevaluation of the combined dexamethasone suppression-corticotropin-releasing hormone test for differentiation of mild Cushing’s disease from pseudo-Cushing’s Syndrome. J Clin Endocrinol Metab 92:4290–4293

    Article  PubMed  CAS  Google Scholar 

  33. Pecori GF, Pivonello R, Ambrogio AG et al (2007) The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing’s syndrome from pseudo-Cushing’s states. Clin Endocrinol (Oxf) 66:251–257

    Article  CAS  Google Scholar 

  34. Erickson D, Natt N, Nippoldt T et al (2007) Dexamethasone-suppressed corticotropin-releasing hormone stimulation test for diagnosis of mild hypercortisolism. J Clin Endocrinol Metab 92:2972–2976

    Article  PubMed  CAS  Google Scholar 

  35. Nieman L (2007) Editorial: The dexamethasone-suppressed corticotropin-releasing hormone test for the diagnosis of Cushing’s syndrome: what have we learned in 14 years? J Clin Endocrinol Metab 92:2876–2878

    Article  PubMed  CAS  Google Scholar 

  36. Lindsay JR, Nieman LK (2005) Differential diagnosis and imaging in Cushing’s syndrome. Endocrinol Metab Clin North Am 34:403–21

    Article  PubMed  CAS  Google Scholar 

  37. Isidori AM, Kaltsas GA, Grossman AB (2006) Ectopic ACTH syndrome. Front Horm Res 35:143–156

    Article  PubMed  CAS  Google Scholar 

  38. Howlett TA, Drury PL, Perry L, Doniach I, Rees LH, Besser GM (1986) Diagnosis and management of ACTH-dependent Cushing’s syndrome: comparison of the features in ectopic and pituitary ACTH production. Clin Endocrinol (Oxf) 24:699–713

    Article  CAS  Google Scholar 

  39. Putignano P, Kaltsas GA, Korbonits M et al (2000) Alterations in serum protein levels in patients with Cushing’s syndrome before and after successful treatment. J Clin Endocrinol Metab 85:3309–3312

    Article  PubMed  CAS  Google Scholar 

  40. Aron DC, Raff H, Findling JW (1997) Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing’s syndrome. J Clin Endocrinol Metab 82:1780–1785

    Article  PubMed  CAS  Google Scholar 

  41. Dichek HL, Nieman LK, Oldfield EH, Pass HI, Malley JD, Cutler GB Jr. (1994) A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing’s syndrome. J Clin Endocrinol Metab 78:418–422

    Article  PubMed  CAS  Google Scholar 

  42. Tyrrell JB, Findling JW, Aron DC, Fitzgerald PA, Forsham PH (1986) An overnight high-dose dexamethasone suppression test for rapid differential diagnosis of Cushing’s syndrome. Ann Intern Med 104:180–186

    PubMed  CAS  Google Scholar 

  43. Bruno OD, Rossi MA, Contreras LN et al (1985) Nocturnal high-dose dexamethasone suppression test in the aetiological diagnosis of Cushing’s syndrome. Acta Endocrinol (Copenh) 109:158–162

    CAS  Google Scholar 

  44. Findling JW, Raff H, Aron DC (2004) The low-dose dexamethasone suppression test: a reevaluation in patients with Cushing’s syndrome. J Clin Endocrinol Metab 89:1222–1226

    Article  PubMed  CAS  Google Scholar 

  45. Isidori AM, Kaltsas GA, Mohammed S et al (2003) Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing’s syndrome. J Clin Endocrinol Metab 88:5299–5306

    Article  PubMed  CAS  Google Scholar 

  46. Dias R, Storr HL, Perry LA, Isidori AM, Grossman AB, Savage MO (2006) The discriminatory value of the low-dose dexamethasone suppression test in the investigation of paediatric Cushing’s syndrome. Horm Res 65:159–162

    Article  PubMed  CAS  Google Scholar 

  47. Trainer PJ, Faria M, Newell-Price J et al (1995) A comparison of the effects of human and ovine corticotropin-releasing hormone on the pituitary-adrenal axis. J Clin Endocrinol Metab 80:412–417

    Article  PubMed  CAS  Google Scholar 

  48. Newell-Price J, Morris DG, Drake WM et al (2002) Optimal response criteria for the human CRH test in the differential diagnosis of ACTH-dependent Cushing’s syndrome. J Clin Endocrinol Metab 87:1640–1645

    Article  PubMed  CAS  Google Scholar 

  49. Invitti C, Pecori GF, de Martin M, Cavagnini F (1999) Diagnosis and management of Cushing’s syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis. J Clin Endocrinol Metab 84:440–448

    Article  PubMed  CAS  Google Scholar 

  50. Nieman LK, Oldfield EH, Wesley R, Chrousos GP, Loriaux DL, Cutler GB Jr. (1993) A simplified morning ovine corticotropin-releasing hormone stimulation test for the differential diagnosis of adrenocorticotropin-dependent Cushing’s syndrome. J Clin Endocrinol Metab 77:1308–1312

    Article  PubMed  CAS  Google Scholar 

  51. Tabarin A, San Galli F, Dezou S et al (1990) The corticotropin-releasing factor test in the differential diagnosis of Cushing’s syndrome: a comparison with the lysine-vasopressin test. Acta Endocrinol (Copenh) 123:331–338

    CAS  Google Scholar 

  52. Malerbi DA, Mendonca BB, Liberman B et al (1993) The desmopressin stimulation test in the differential diagnosis of Cushing’s syndrome. Clin Endocrinol (Oxf) 38:463–472

    Article  CAS  Google Scholar 

  53. Newell-Price J, Perry L, Medbak S et al (1997) A combined test using desmopressin and corticotropin-releasing hormone in the differential diagnosis of Cushing’s syndrome. J Clin Endocrinol Metab 82:176–181

    Article  PubMed  CAS  Google Scholar 

  54. Tsagarakis S, Tsigos C, Vasiliou V et al (2002) The desmopressin and combined CRH-desmopressin tests in the differential diagnosis of ACTH-dependent Cushing’s syndrome: constraints imposed by the expression of V2 vasopressin receptors in tumors with ectopic ACTH secretion. J Clin Endocrinol Metab 87:1646–1653

    Article  PubMed  CAS  Google Scholar 

  55. Malerbi DA, Fragoso MC, Vieira Filho AH, Brenlha EM, Mendonca BB (1996) Cortisol and adrenocorticotropin response to desmopressin in women with Cushing’s disease compared with depressive illness. J Clin Endocrinol Metab 81:2233–2237

    Article  PubMed  CAS  Google Scholar 

  56. Korbonits M, Kaltsas G, Perry LA et al (1999) The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal axis via arginine vasopressin. J Clin Endocrinol Metab 84:2489–2495

    Article  PubMed  CAS  Google Scholar 

  57. Ghigo E, Arvat E, Ramunni J et al (1997) Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing’s syndrome. J Clin Endocrinol Metab 82:2439–2444

    Article  PubMed  CAS  Google Scholar 

  58. Arvat E, Giordano R, Ramunni J et al (1998) Adrenocorticotropin and cortisol hyperresponsiveness to hexarelin in patients with Cushing’s disease bearing a pituitary microadenoma, but not in those with macroadenoma. J Clin Endocrinol Metab 83:4207–4211

    Article  PubMed  CAS  Google Scholar 

  59. Korbonits M, Jacobs RA, Aylwin SJ et al (1998) Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors. J Clin Endocrinol Metab 83:3624–3630

    Article  PubMed  CAS  Google Scholar 

  60. Arnaldi G, Mancini T, Kola B et al (2003) Cyclical Cushing’s syndrome in a patient with a bronchial neuroendocrine tumor (typical carcinoid) expressing ghrelin and growth hormone secretagogue receptors. J Clin Endocrinol Metab 88:5834–5840

    Article  PubMed  CAS  Google Scholar 

  61. Machado MC, Sa SV, Goldbaum TS et al (2007) In vivo response to growth hormone-releasing peptide-6 in adrenocorticotropin-dependent Cushing’s syndrome by lung carcinoid tumor is associated with growth hormone secretagogue receptor type 1a mRNA expression. J Endocrinol Invest 30:334–340

    PubMed  CAS  Google Scholar 

  62. Kaltsas GA, Giannulis MG, Newell-Price JD et al (1999) A critical analysis of the value of simultaneous inferior petrosal sinus sampling in Cushing’s disease and the occult ectopic adrenocorticotropin syndrome. J Clin Endocrinol Metab 84:487–492

    Article  PubMed  CAS  Google Scholar 

  63. Kaskarelis IS, Tsatalou EG, Benakis SV et al (2006) Bilateral inferior petrosal sinuses sampling in the routine investigation of Cushing’s syndrome: a comparison with MRI. AJR Am J Roentgenol 187:562–570

    Article  PubMed  Google Scholar 

  64. Oldfield EH, Doppman JL, Nieman LK et al (1991) Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing’s syndrome. N Engl J Med 325:897–905

    Article  PubMed  CAS  Google Scholar 

  65. Colao A, Faggiano A, Pivonello R, Pecori GF, Cavagnini F, Lombardi G (2001) Inferior petrosal sinus sampling in the differential diagnosis of Cushing’s syndrome: results of an Italian multicenter study. Eur J Endocrinol 144:499–507

    Article  PubMed  CAS  Google Scholar 

  66. Swearingen B, Katznelson L, Miller K et al (2004) Diagnostic errors after inferior petrosal sinus sampling. J Clin Endocrinol Metab 89:3752–3763

    Article  PubMed  CAS  Google Scholar 

  67. Castinetti F, Morange I, Dufour H et al (2007) Desmopressin test during petrosal sinus sampling: a valuable tool to discriminate pituitary or ectopic ACTH-dependent Cushing’s syndrome. Eur J Endocrinol 157:271–277

    Article  PubMed  CAS  Google Scholar 

  68. Miller DL, Doppman JL, Nieman LK et al (1990) Petrosal sinus sampling: discordant lateralization of ACTH-secreting pituitary microadenomas before and after stimulation with corticotropin-releasing hormone. Radiology 176:429–431

    PubMed  CAS  Google Scholar 

  69. Batista D, Gennari M, Riar J et al (2006) An assessment of petrosal sinus sampling for localization of pituitary microadenomas in children with Cushing disease. J Clin Endocrinol Metab 91:221–224

    Article  PubMed  CAS  Google Scholar 

  70. Lin LY, Teng MM, Huang CI et al (2007) Assessment of bilateral inferior petrosal sinus sampling (BIPSS) in the diagnosis of Cushing’s disease. J Chin Med Assoc 70:4–10

    PubMed  CAS  Google Scholar 

  71. Lienhardt A, Grossman AB, Dacie JE et al (2001) Relative contributions of inferior petrosal sinus sampling and pituitary imaging in the investigation of children and adolescents with ACTH-dependent Cushing’s syndrome. J Clin Endocrinol Metab 86:5711–5714

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Endocrinology, Barts and the London, Queen Mary’s School of Medicine, University of London, London, EC1M 6BQ, UK

    Blerina Kola & Ashley B. Grossman

  2. Department of Endocrinology, St. Bartholomew’s Hospital, London, EC1A 7BE, UK

    Ashley B. Grossman

Authors
  1. Blerina Kola
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ashley B. Grossman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ashley B. Grossman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kola, B., Grossman, A.B. Dynamic testing in Cushing’s syndrome. Pituitary 11, 155–162 (2008). https://doi.org/10.1007/s11102-007-0079-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11102-007-0079-x

Keywords

Search

Navigation